img

Global Oncology Medication Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oncology Medication Market Insights, Forecast to 2034

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.

Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
Market Analysis and InsightsGlobal Oncology Medication Market
Global Oncology Medication market is expected to reach to US$ 215600 million in 2024, with a positive growth of %, compared with US$ 197440 million in 2022. Backed with the increasing demand from downstream industries, Oncology Medication industry is evaluated to reach US$ 342140 million in 2029. The CAGR will be 8.0% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Oncology Medication market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oncology Medication market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Segment by Type
Chemotherapy Medication
Targeted Therapy Medication
Immunotherapy Medication
Hormonal Therapy Medication
Others

Segment by Application


Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Oncology Medication introduction, etc. Oncology Medication Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Oncology Medication
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Chemotherapy Medication
1.2.3 Targeted Therapy Medication
1.2.4 Immunotherapy Medication
1.2.5 Hormonal Therapy Medication
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Medication Market Perspective (2018-2029)
2.2 Global Oncology Medication Growth Trends by Region
2.2.1 Oncology Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oncology Medication Historic Market Size by Region (2018-2024)
2.2.3 Oncology Medication Forecasted Market Size by Region (2024-2029)
2.3 Oncology Medication Market Dynamics
2.3.1 Oncology Medication Industry Trends
2.3.2 Oncology Medication Market Drivers
2.3.3 Oncology Medication Market Challenges
2.3.4 Oncology Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oncology Medication by Players
3.1.1 Global Oncology Medication Revenue by Players (2018-2024)
3.1.2 Global Oncology Medication Revenue Market Share by Players (2018-2024)
3.2 Global Oncology Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oncology Medication, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Oncology Medication Market Concentration Ratio
3.4.1 Global Oncology Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Medication Revenue in 2022
3.5 Global Key Players of Oncology Medication Head office and Area Served
3.6 Global Key Players of Oncology Medication, Product and Application
3.7 Global Key Players of Oncology Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Medication Breakdown Data by Type
4.1 Global Oncology Medication Historic Market Size by Type (2018-2024)
4.2 Global Oncology Medication Forecasted Market Size by Type (2024-2029)
5 Oncology Medication Breakdown Data by Application
5.1 Global Oncology Medication Historic Market Size by Application (2018-2024)
5.2 Global Oncology Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oncology Medication Market Size (2018-2029)
6.2 North America Oncology Medication Market Size by Type
6.2.1 North America Oncology Medication Market Size by Type (2018-2024)
6.2.2 North America Oncology Medication Market Size by Type (2024-2029)
6.2.3 North America Oncology Medication Market Share by Type (2018-2029)
6.3 North America Oncology Medication Market Size by Application
6.3.1 North America Oncology Medication Market Size by Application (2018-2024)
6.3.2 North America Oncology Medication Market Size by Application (2024-2029)
6.3.3 North America Oncology Medication Market Share by Application (2018-2029)
6.4 North America Oncology Medication Market Size by Country
6.4.1 North America Oncology Medication Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Oncology Medication Market Size by Country (2018-2024)
6.4.3 North America Oncology Medication Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Oncology Medication Market Size (2018-2029)
7.2 Europe Oncology Medication Market Size by Type
7.2.1 Europe Oncology Medication Market Size by Type (2018-2024)
7.2.2 Europe Oncology Medication Market Size by Type (2024-2029)
7.2.3 Europe Oncology Medication Market Share by Type (2018-2029)
7.3 Europe Oncology Medication Market Size by Application
7.3.1 Europe Oncology Medication Market Size by Application (2018-2024)
7.3.2 Europe Oncology Medication Market Size by Application (2024-2029)
7.3.3 Europe Oncology Medication Market Share by Application (2018-2029)
7.4 Europe Oncology Medication Market Size by Country
7.4.1 Europe Oncology Medication Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Oncology Medication Market Size by Country (2018-2024)
7.4.3 Europe Oncology Medication Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oncology Medication Market Size (2018-2029)
8.2 China Oncology Medication Market Size by Type
8.2.1 China Oncology Medication Market Size by Type (2018-2024)
8.2.2 China Oncology Medication Market Size by Type (2024-2029)
8.2.3 China Oncology Medication Market Share by Type (2018-2029)
8.3 China Oncology Medication Market Size by Application
8.3.1 China Oncology Medication Market Size by Application (2018-2024)
8.3.2 China Oncology Medication Market Size by Application (2024-2029)
8.3.3 China Oncology Medication Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oncology Medication Market Size (2018-2029)
9.2 Asia Oncology Medication Market Size by Type
9.2.1 Asia Oncology Medication Market Size by Type (2018-2024)
9.2.2 Asia Oncology Medication Market Size by Type (2024-2029)
9.2.3 Asia Oncology Medication Market Share by Type (2018-2029)
9.3 Asia Oncology Medication Market Size by Application
9.3.1 Asia Oncology Medication Market Size by Application (2018-2024)
9.3.2 Asia Oncology Medication Market Size by Application (2024-2029)
9.3.3 Asia Oncology Medication Market Share by Application (2018-2029)
9.4 Asia Oncology Medication Market Size by Region
9.4.1 Asia Oncology Medication Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Oncology Medication Market Size by Region (2018-2024)
9.4.3 Asia Oncology Medication Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oncology Medication Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Oncology Medication Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oncology Medication Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Oncology Medication Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Oncology Medication Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Oncology Medication Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oncology Medication Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Oncology Medication Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Oncology Medication Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Oncology Medication Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oncology Medication Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Oncology Medication Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Oncology Medication Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Medication Introduction
11.1.4 Roche Revenue in Oncology Medication Business (2018-2024)
11.1.5 Roche Recent Developments
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Oncology Medication Introduction
11.2.4 Celgene Revenue in Oncology Medication Business (2018-2024)
11.2.5 Celgene Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Oncology Medication Introduction
11.3.4 Novartis Revenue in Oncology Medication Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Oncology Medication Introduction
11.4.4 Bristol-Myers Squibb Revenue in Oncology Medication Business (2018-2024)
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Oncology Medication Introduction
11.5.4 Johnson & Johnson Revenue in Oncology Medication Business (2018-2024)
11.5.5 Johnson & Johnson Recent Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Oncology Medication Introduction
11.6.4 Merck & Co. Revenue in Oncology Medication Business (2018-2024)
11.6.5 Merck & Co. Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Oncology Medication Introduction
11.7.4 AstraZeneca Revenue in Oncology Medication Business (2018-2024)
11.7.5 AstraZeneca Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Oncology Medication Introduction
11.8.4 Pfizer Revenue in Oncology Medication Business (2018-2024)
11.8.5 Pfizer Recent Developments
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Oncology Medication Introduction
11.9.4 Amgen Revenue in Oncology Medication Business (2018-2024)
11.9.5 Amgen Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Oncology Medication Introduction
11.10.4 Takeda Revenue in Oncology Medication Business (2018-2024)
11.10.5 Takeda Recent Developments
11.11 Astellas
11.11.1 Astellas Company Details
11.11.2 Astellas Business Overview
11.11.3 Astellas Oncology Medication Introduction
11.11.4 Astellas Revenue in Oncology Medication Business (2018-2024)
11.11.5 Astellas Recent Developments
11.12 Ipsen
11.12.1 Ipsen Company Details
11.12.2 Ipsen Business Overview
11.12.3 Ipsen Oncology Medication Introduction
11.12.4 Ipsen Revenue in Oncology Medication Business (2018-2024)
11.12.5 Ipsen Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Oncology Medication Introduction
11.13.4 Sanofi Revenue in Oncology Medication Business (2018-2024)
11.13.5 Sanofi Recent Developments
11.14 Bayer
11.14.1 Bayer Company Details
11.14.2 Bayer Business Overview
11.14.3 Bayer Oncology Medication Introduction
11.14.4 Bayer Revenue in Oncology Medication Business (2018-2024)
11.14.5 Bayer Recent Developments
11.15 Biogen Idec
11.15.1 Biogen Idec Company Details
11.15.2 Biogen Idec Business Overview
11.15.3 Biogen Idec Oncology Medication Introduction
11.15.4 Biogen Idec Revenue in Oncology Medication Business (2018-2024)
11.15.5 Biogen Idec Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oncology Medication Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Chemotherapy Medication
Table 3. Key Players of Targeted Therapy Medication
Table 4. Key Players of Immunotherapy Medication
Table 5. Key Players of Hormonal Therapy Medication
Table 6. Key Players of Others
Table 7. Global Oncology Medication Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Oncology Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Oncology Medication Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Oncology Medication Market Share by Region (2018-2024)
Table 11. Global Oncology Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Oncology Medication Market Share by Region (2024-2029)
Table 13. Oncology Medication Market Trends
Table 14. Oncology Medication Market Drivers
Table 15. Oncology Medication Market Challenges
Table 16. Oncology Medication Market Restraints
Table 17. Global Oncology Medication Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Oncology Medication Revenue Share by Players (2018-2024)
Table 19. Global Top Oncology Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Medication as of 2022)
Table 20. Global Oncology Medication Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by Oncology Medication Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of Oncology Medication, Headquarters and Area Served
Table 23. Global Key Players of Oncology Medication, Product and Application
Table 24. Global Key Players of Oncology Medication, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Medication Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Oncology Medication Revenue Market Share by Type (2018-2024)
Table 28. Global Oncology Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Oncology Medication Revenue Market Share by Type (2024-2029)
Table 30. Global Oncology Medication Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Oncology Medication Revenue Share by Application (2018-2024)
Table 32. Global Oncology Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Oncology Medication Revenue Share by Application (2024-2029)
Table 34. North America Oncology Medication Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America Oncology Medication Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Oncology Medication Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America Oncology Medication Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Oncology Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Oncology Medication Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America Oncology Medication Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Oncology Medication Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe Oncology Medication Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Oncology Medication Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe Oncology Medication Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Oncology Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Oncology Medication Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe Oncology Medication Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Oncology Medication Market Size by Type (2018-2024) & (US$ Million)
Table 49. China Oncology Medication Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Oncology Medication Market Size by Application (2018-2024) & (US$ Million)
Table 51. China Oncology Medication Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Oncology Medication Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia Oncology Medication Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Oncology Medication Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia Oncology Medication Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Oncology Medication Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Oncology Medication Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia Oncology Medication Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oncology Medication Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oncology Medication Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oncology Medication Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Oncology Medication Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Oncology Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Oncology Medication Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Oncology Medication Market Size by Country (2024-2029) & (US$ Million)
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Oncology Medication Product
Table 69. Roche Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 70. Roche Recent Developments
Table 71. Celgene Company Details
Table 72. Celgene Business Overview
Table 73. Celgene Oncology Medication Product
Table 74. Celgene Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 75. Celgene Recent Developments
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Oncology Medication Product
Table 79. Novartis Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 80. Novartis Recent Developments
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Oncology Medication Product
Table 84. Bristol-Myers Squibb Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Developments
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Oncology Medication Product
Table 89. Johnson & Johnson Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 90. Johnson & Johnson Recent Developments
Table 91. Merck & Co. Company Details
Table 92. Merck & Co. Business Overview
Table 93. Merck & Co. Oncology Medication Product
Table 94. Merck & Co. Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 95. Merck & Co. Recent Developments
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Oncology Medication Product
Table 99. AstraZeneca Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 100. AstraZeneca Recent Developments
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Oncology Medication Product
Table 104. Pfizer Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 105. Pfizer Recent Developments
Table 106. Amgen Company Details
Table 107. Amgen Business Overview
Table 108. Amgen Oncology Medication Product
Table 109. Amgen Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 110. Amgen Recent Developments
Table 111. Takeda Company Details
Table 112. Takeda Business Overview
Table 113. Takeda Oncology Medication Product
Table 114. Takeda Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 115. Takeda Recent Developments
Table 116. Astellas Company Details
Table 117. Astellas Business Overview
Table 118. Astellas Oncology Medication Product
Table 119. Astellas Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 120. Astellas Recent Developments
Table 121. Ipsen Company Details
Table 122. Ipsen Business Overview
Table 123. Ipsen Oncology Medication Product
Table 124. Ipsen Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 125. Ipsen Recent Developments
Table 126. Sanofi Company Details
Table 127. Sanofi Business Overview
Table 128. Sanofi Oncology Medication Product
Table 129. Sanofi Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 130. Sanofi Recent Developments
Table 131. Bayer Company Details
Table 132. Bayer Business Overview
Table 133. Bayer Oncology Medication Product
Table 134. Bayer Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 135. Bayer Recent Developments
Table 136. Biogen Idec Company Details
Table 137. Biogen Idec Business Overview
Table 138. Biogen Idec Oncology Medication Product
Table 139. Biogen Idec Revenue in Oncology Medication Business (2018-2024) & (US$ Million)
Table 140. Biogen Idec Recent Developments
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Oncology Medication Market Share by Type: 2022 VS 2029
Figure 3. Chemotherapy Medication Features
Figure 4. Targeted Therapy Medication Features
Figure 5. Immunotherapy Medication Features
Figure 6. Hormonal Therapy Medication Features
Figure 7. Others Features
Figure 8. Global Oncology Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Oncology Medication Market Share by Application: 2022 VS 2029
Figure 10. Blood Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Gastrointestinal Cancer Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Respiratory or Lung Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Oncology Medication Report Years Considered
Figure 17. Global Oncology Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Oncology Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Oncology Medication Market Share by Region: 2022 VS 2029
Figure 20. Global Oncology Medication Market Share by Players in 2022
Figure 21. Global Top Oncology Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Medication as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Oncology Medication Revenue in 2022
Figure 23. North America Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Oncology Medication Market Share by Type (2018-2029)
Figure 25. North America Oncology Medication Market Share by Application (2018-2029)
Figure 26. North America Oncology Medication Market Share by Country (2018-2029)
Figure 27. United States Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Oncology Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 30. Europe Oncology Medication Market Share by Type (2018-2029)
Figure 31. Europe Oncology Medication Market Share by Application (2018-2029)
Figure 32. Europe Oncology Medication Market Share by Country (2018-2029)
Figure 33. Germany Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. France Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. U.K. Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Italy Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Russia Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Nordic Countries Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. China Oncology Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 40. China Oncology Medication Market Share by Type (2018-2029)
Figure 41. China Oncology Medication Market Share by Application (2018-2029)
Figure 42. Asia Oncology Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 43. Asia Oncology Medication Market Share by Type (2018-2029)
Figure 44. Asia Oncology Medication Market Share by Application (2018-2029)
Figure 45. Asia Oncology Medication Market Share by Region (2018-2029)
Figure 46. Japan Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. South Korea Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. China Taiwan Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Southeast Asia Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. India Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Australia Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Oncology Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Oncology Medication Market Share by Type (2018-2029)
Figure 54. Middle East, Africa, and Latin America Oncology Medication Market Share by Application (2018-2029)
Figure 55. Middle East, Africa, and Latin America Oncology Medication Market Share by Country (2018-2029)
Figure 56. Brazil Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Mexico Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Turkey Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Israel Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. GCC Countries Oncology Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. Roche Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 63. Celgene Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 64. Novartis Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 66. Johnson & Johnson Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 67. Merck & Co. Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 68. AstraZeneca Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 69. Pfizer Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 70. Amgen Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 71. Takeda Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 72. Astellas Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 73. Ipsen Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 74. Sanofi Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 75. Bayer Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 76. Biogen Idec Revenue Growth Rate in Oncology Medication Business (2018-2024)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries